Location History:
- São Paulo SP, BR (2012)
- São Paulo, BR (2015)
Company Filing History:
1 out of 17 
1 out of 1 
1 out of 10 Years Active: 2012-2015
Title: Katsuhiro Konno: Innovator in Analgesic Peptides and Genetic Material Interaction
Introduction
Katsuhiro Konno is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the field of peptide analogs and their applications in medicine. With a total of 2 patents, his work focuses on innovative solutions for pain management and genetic material interaction.
Latest Patents
Konno's latest patents include groundbreaking inventions related to analgesic peptides derived from snakes. The first patent refers to analog compounds of peptides with specific amino acid sequences, which are utilized in the treatment, diagnosis, and prevention of painful conditions mediated by opioid receptors. This invention also encompasses pharmaceutical compositions and methods for preparation and purification, aimed at identifying analgesic compounds.
The second patent involves the use of crotamine, a polypeptide that interacts with genetic material. Under submicromolar quantities, crotamine exhibits non-toxic properties, allowing for selective cell penetration and transport of molecules to various cellular compartments. This invention includes compositions for treating diseases based on its interaction with DNA and RNA, as well as a kit for transfecting or identifying actively proliferating cells.
Career Highlights
Throughout his career, Katsuhiro Konno has worked with various organizations, including the Fundação de Amparo à Pesquisa do Estado de São Paulo. His innovative research has positioned him as a key figure in the development of new therapeutic approaches.
Collaborations
Konno has collaborated with notable colleagues such as Yara Cury and Gisele Picolo. Their combined expertise has contributed to advancing research in the fields of peptides and genetic material interaction.
Conclusion
Katsuhiro Konno's contributions to the field of analgesic peptides and genetic material interaction highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to advancing scientific knowledge and developing effective solutions for pain management and cellular therapies.